About
4.13CHF+0.14 +3.51%
Closed • Updated at 11:40 GMT+00:00Market Cap$1.33B
Volume2.04M
Beta1.11
RSI56.65
Gross Margin82.61%
Idorsia Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
May 6 2026
Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2026
Apr 28 2026
Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year
Apr 10 2026
Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders
Apr 9 2026
Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development
Mar 30 2026
Idorsia’s daridorexant delivers outstanding results in a Phase 2 study in children with insomnia disorder
Recent Videos

Intervista a Giovanni Girgenti, General Manager, Idorsia Pharmaceuticals Italy - Task Force Italia
May 04, 2026

Werner Waldmann (BSD) im Gespräch mit Dr. Andreas Uttenweiler (Idorsia)
Apr 16, 2026

Idorsia’s Daridorexant Shows Strong Results In Phase 2 Pediatric Insomnia Study
Apr 01, 2026

Intervista dott. Giovanni Girgenti General Manager Idorsia
Mar 13, 2026
Community Chat
Ask AI
Try asking
Translate